DK0655065T3 - - Google Patents

Info

Publication number
DK0655065T3
DK0655065T3 DK93919994.9T DK93919994T DK0655065T3 DK 0655065 T3 DK0655065 T3 DK 0655065T3 DK 93919994 T DK93919994 T DK 93919994T DK 0655065 T3 DK0655065 T3 DK 0655065T3
Authority
DK
Denmark
Prior art keywords
hydroxyrapamycin
formula
compound
deoxo
immunosuppressive
Prior art date
Application number
DK93919994.9T
Other languages
Danish (da)
English (en)
Inventor
Frances Christy Nelson
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/009,605 external-priority patent/US5256790A/en
Application filed by American Home Prod filed Critical American Home Prod
Application granted granted Critical
Publication of DK0655065T3 publication Critical patent/DK0655065T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Transplantation (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK93919994.9T 1992-08-13 1993-08-12 DK0655065T3 (enFirst)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US93012492A 1992-08-13 1992-08-13
US08/009,605 US5256790A (en) 1992-08-13 1993-01-27 27-hydroxyrapamycin and derivatives thereof

Publications (1)

Publication Number Publication Date
DK0655065T3 true DK0655065T3 (enFirst) 1997-02-24

Family

ID=26679675

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93919994.9T DK0655065T3 (enFirst) 1992-08-13 1993-08-12

Country Status (12)

Country Link
EP (1) EP0655065B1 (enFirst)
JP (1) JPH08501084A (enFirst)
AT (1) ATE146179T1 (enFirst)
AU (1) AU5007193A (enFirst)
CA (1) CA2142288A1 (enFirst)
DE (1) DE69306585T2 (enFirst)
DK (1) DK0655065T3 (enFirst)
ES (1) ES2096941T3 (enFirst)
GR (1) GR3022730T3 (enFirst)
HU (1) HU221499B (enFirst)
MX (1) MX9304868A (enFirst)
WO (1) WO1994004540A1 (enFirst)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5527907A (en) * 1993-11-19 1996-06-18 Abbott Laboratories Macrolide immunomodulators
EP0729471A1 (en) * 1993-11-19 1996-09-04 Abbott Laboratories Semisynthetic analogs of rapamycin (macrolides) being immunomodulators
US6187757B1 (en) 1995-06-07 2001-02-13 Ariad Pharmaceuticals, Inc. Regulation of biological events using novel compounds
DE69624921T2 (de) 1995-06-09 2003-09-11 Novartis Ag, Basel Rapamycinderivate
IL147803A0 (en) 1999-08-24 2002-08-14 Ariad Gene Therapeutics Inc 28-epirapalogs
US7067526B1 (en) 1999-08-24 2006-06-27 Ariad Gene Therapeutics, Inc. 28-epirapalogs
EP1478648B1 (en) 2002-02-01 2014-04-30 ARIAD Pharmaceuticals, Inc. Phosphorus-containing compounds and uses thereof
WO2004060346A2 (en) 2002-12-30 2004-07-22 Angiotech International Ag Drug delivery from rapid gelling polymer composition
EP1768662A2 (en) 2004-06-24 2007-04-04 Novartis Vaccines and Diagnostics, Inc. Small molecule immunopotentiators and assays for their detection
CA2669415A1 (en) 2006-11-14 2008-05-22 Ariad Pharmaceuticals, Inc. Solid dosage form comprising ap23573
EP2245165A4 (en) 2008-01-11 2011-06-01 Massachusetts Eye & Ear Infirm TRANSGENIC CONDITIONAL STOP DIMERICABLE CASPASE ANIMALS
CN105283553B (zh) 2013-06-11 2021-06-25 克隆技术实验室有限公司 蛋白质富集的微泡及其制备和使用方法
PL3788049T3 (pl) 2018-05-01 2023-06-19 Revolution Medicines, Inc. Połączone z C40, C28 i C32 analogi rapamycyny jako inhibitory mTOR
EP3788050B1 (en) 2018-05-01 2024-08-28 Revolution Medicines, Inc. C26-linked rapamycin analogs as mtor inhibitors
AU2022253019A1 (en) * 2021-04-09 2023-11-16 Revolution Medicines, Inc. Synthesis of rapamycin analog compounds
EP4531859A4 (en) 2022-05-25 2026-05-27 Revolution Medicines Inc CANCER TREATMENT METHODS USING AN MTOR INHIBITOR

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04230389A (ja) * 1990-07-16 1992-08-19 American Home Prod Corp ラパマイシン誘導体
US5102876A (en) * 1991-05-07 1992-04-07 American Home Products Corporation Reduction products of rapamycin

Also Published As

Publication number Publication date
GR3022730T3 (en) 1997-06-30
DE69306585D1 (de) 1997-01-23
ATE146179T1 (de) 1996-12-15
WO1994004540A1 (en) 1994-03-03
AU5007193A (en) 1994-03-15
HU221499B (en) 2002-10-28
JPH08501084A (ja) 1996-02-06
CA2142288A1 (en) 1994-03-03
HUT71614A (en) 1996-01-29
HU9500432D0 (en) 1995-04-28
ES2096941T3 (es) 1997-03-16
MX9304868A (es) 1994-05-31
EP0655065A1 (en) 1995-05-31
EP0655065B1 (en) 1996-12-11
DE69306585T2 (de) 1997-04-17

Similar Documents

Publication Publication Date Title
GR3022730T3 (en) 27-hydroxyrapamycin and derivatives thereof.
ES2085726T3 (es) Derivado prolinico de rapamicina, su produccion y aplicacion.
NZ297661A (en) Hindered N-oxide esters of rapamycin and pharmaceutical compositions
AU6858791A (en) Uracil derivatives and pesticides containing the same as active ingredient
TW360678B (en) Synergistic stabilizer mixture for polyolefins
ATE119774T1 (de) Imidazopyridinderivate und ihre verwendung.
NO974890D0 (no) Radicicolderivater
TW256832B (enFirst)
TW223637B (enFirst)
AU2623192A (en) Antifungal agent
ZA9410023B (en) Herbicides
AU641686B2 (en) Benzanilides
AP9400632A0 (en) Ether derivatives.
CA2111955A1 (en) Novel tetracyclic compound
AU621996B2 (en) 2,5,6,7-tetranor-4,8-inter-m-phenylene pgi2 derivatives
GR1002598B (el) Παραγωγα επι-επιβατιδινης.
IE55842B1 (en) Cardiotonic agents
UY24327A1 (es) Derivados de cefalosporina
MY115430A (en) Glutaramide derivatives.
AU1446892A (en) Novel oxa- or azasteroid derivative
AU7020996A (en) UCK14 compounds
AP9400608A0 (en) "New nicotinic acid derivative".
CA2032311A1 (en) 2,19-methyleneoxy and 2,19-methylenethio bridged steroids as aromatase and 19-hydroxylase inhibitors
DK0565059T3 (da) Indolderivat
UA43324C2 (uk) Протитромботичний засіб